Answers are grounded in this paper and cite their sources.
Rare neurodevelopmental disorders (NDDs) are clinically and genetically heterogeneous conditions affecting brain function, and a comprehensive set of NDD-associated genes is still lacking. We integrated gene lists from Orphanet, SFARI Gene, GeneTrek, and a large-scale genomic study, and classified 19,354 human protein-coding genes into 2639 high-confidence genes, 6856 candidate genes, and 9859 genes with no NDD evidence. Enrichment analysis of the high-confidence set highlighted nervous system development, synaptic processes, tRNA aminoacylation, and cancer-related pathways, and Monarch Disease Ontology (MONDO) enrichment confirmed its association with NDDs. We then prioritized candidate genes with a Multi-Ontology Enrichment (MOE) score, which counts the annotation resources in which a gene shares enriched terms with the high-confidence set. Higher MOE scores were associated with stronger loss-of-function constraint in the Genome Aggregation Database (gnomAD) a larger fraction of genes with pathogenic ClinVar variants (10.7% to 44.0%), and more frequent gene-level association in NDD sequencing cohorts (2.8% to 8.3%), and SysNDD scores provided further support. Part of this signal reflects how well genes are annotated, which we discuss as a limitation. Overall, this work provides a harmonized NDD gene resource and a transparent prioritization of candidate genes for diagnostic and functional studies.
No takes yet. Share an insight, caveat, or question.
Rivi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: